Keywords: second, lunesta, trial, confirms, efficacy, pharmaceutical, group

Second Lunesta trial confirms efficacy

Article | 18 April 2005

Print This

US pharmaceutical group Sepracor says that preliminary results from the second six-month safety and efficacy study of its insomnia drug, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in